Boehringer Ingelheim Ventures

Funding rounds backed by Boehringer Ingelheim Ventures.

Export CSV
Funding disclosed in full
$8M
Median round
$8M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
STRM.BIO

Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy

$8MSeed2BiotechUnited States
4 participantsBlue Bay Capital FundBoehringer Ingelheim VenturesDelos CapitalRecordati